Table 1.
Parameter | Frequency | Number of evaluated patients | Percent |
---|---|---|---|
Demographic data | |||
Age (years) | |||
<18 | 90 | 159 | 56.6 |
18-35 | 55 | 159 | 34.6 |
>35 | 14 | 159 | 8.8 |
Gender | |||
Male | 90 | 159 | 56.6 |
Female | 69 | 159 | 43.4 |
Splenectomized | 52 | 159 | 32.7 |
Serum ferritin (μg/L) | |||
<1000 | 122 | 159 | 76.7 |
>1000 | 37 | 159 | 23.3 |
Treatment | |||
None transfused | 33 | 159 | 20.7 |
Occasional transfusion | 75 | 159 | 47.2 |
Regular transfusion | 51 | 159 | 32.1 |
Iron chelation | 63 | 159 | 39.6 |
Hydroxyurea | 75 | 159 | 47.2 |
Complications | |||
Facial deformity | 99 | 159 | 62.3 |
∗Osteoporosis | 17 | 60 | 28.3 |
∗∗Growth retardation | 17 | 90 | 18.9 |
∗∗∗Subclinical hypothyroidism | 22 | 131 | 16.8 |
∗∗∗∗Cholelithiasis | 19 | 137 | 13.8 |
Pulmonary hypertension | 18 | 159 | 11.3 |
Abnormal liver function | 12 | 159 | 7.5 |
Thrombosis | 2 | 159 | 1.3 |
EMH | 1 | 159 | 0.6 |
Leg ulcer | 1 | 159 | 0.6 |
∗Osteoporosis and ∗∗∗subclinical hypothyroidism were evaluated in patients ≥ 10 years old and/or symptomatic, ∗∗growth retardation (height > 2SD below 3rd percentile for the mean age and gender) in patients ≤ 18 years, and ∗∗∗∗cholelithiasis estimated in 137 patients excluding the 22 patients that underwent cholecystectomy.